Cellavision Ab Stock Performance
| CLVSF Stock | USD 15.85 0.40 2.59% |
The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CellaVision's returns are expected to increase less than the market. However, during the bear market, the loss of holding CellaVision is expected to be smaller as well. At this point, CellaVision AB has a negative expected return of -0.0846%. Please make sure to confirm CellaVision's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if CellaVision AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, CellaVision is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 102.3 M | |
| Total Cashflows From Investing Activities | -84.3 M |
CellaVision |
CellaVision Relative Risk vs. Return Landscape
If you would invest 1,683 in CellaVision AB on November 12, 2025 and sell it today you would lose (98.00) from holding CellaVision AB or give up 5.82% of portfolio value over 90 days. CellaVision AB is currently producing negative expected returns and takes up 1.4184% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than CellaVision, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CellaVision Target Price Odds to finish over Current Price
The tendency of CellaVision Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.85 | 90 days | 15.85 | about 98.0 |
Based on a normal probability distribution, the odds of CellaVision to move above the current price in 90 days from now is about 98.0 (This CellaVision AB probability density function shows the probability of CellaVision Pink Sheet to fall within a particular range of prices over 90 days) .
CellaVision Price Density |
| Price |
Predictive Modules for CellaVision
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CellaVision AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CellaVision's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CellaVision Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CellaVision is not an exception. The market had few large corrections towards the CellaVision's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CellaVision AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CellaVision within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.35 | |
β | Beta against Dow Jones | 0.82 | |
σ | Overall volatility | 0.52 | |
Ir | Information ratio | -0.17 |
CellaVision Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CellaVision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CellaVision AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CellaVision AB generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are held by company insiders |
CellaVision Fundamentals Growth
CellaVision Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CellaVision, and CellaVision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CellaVision Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.19 % | |||
| Current Valuation | 600.98 M | |||
| Shares Outstanding | 23.85 M | |||
| Price To Earning | 46.79 X | |||
| Price To Book | 9.14 X | |||
| Price To Sales | 8.50 X | |||
| Revenue | 565.55 M | |||
| EBITDA | 193.6 M | |||
| Cash And Equivalents | 18.51 M | |||
| Cash Per Share | 0.78 X | |||
| Debt To Equity | 0.20 % | |||
| Book Value Per Share | 1.22 X | |||
| Cash Flow From Operations | 159.72 M | |||
| Earnings Per Share | 0.50 X | |||
| Total Asset | 825.21 M | |||
About CellaVision Performance
By analyzing CellaVision's fundamental ratios, stakeholders can gain valuable insights into CellaVision's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CellaVision has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CellaVision has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden. Cellavision is traded on OTC Exchange in the United States.Things to note about CellaVision AB performance evaluation
Checking the ongoing alerts about CellaVision for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CellaVision AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CellaVision AB generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are held by company insiders |
- Analyzing CellaVision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CellaVision's stock is overvalued or undervalued compared to its peers.
- Examining CellaVision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CellaVision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CellaVision's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CellaVision's pink sheet. These opinions can provide insight into CellaVision's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CellaVision Pink Sheet analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |